Sfoglia per Autore
Effects of taurine in chronic experimental epilepsy.
1974-01-01 MUTANI R ;BERGAMINI L ;DELSEDIME M ;DURELLI L
Interferon alpha-2a treatment of relapsing-remitting multiple sclerosis: Disease activity resumes after stopping treatment
1996-01-01 L. Durelli; M. R. Bongioanni; B. Ferrero; R. Ferri; D. Imperiale; G. B. Bradac; M. Bergui; M. Geuna; L. Bergamini; B. Bergamasco
Autoimmune events during interferon beta-1b treatment for multiple sclerosis.
1999-01-01 DURELLI L; FERRERO B; OGGERO A; VERDUN E; BONGIOANNI MR; GENTILE E; ISOARDO GL; RICCI A; ROTA E; BERGAMASCO B; M. DURAZZO; SARACCO G; BIAVA MA; BROSSA PC; GIORDA L; PAGNI R; AIMO G
A Meta-Analysis Of Methylprednisolone In Recovery From Multiple Sclerosis Exacerbations
2000-01-01 D.M. MILLER; B. WEINSTOCK-GUTTMAN; F. BTHOUX; J. LEE; G. BECK; V. BLOCK; L. DURELLI; L. LAMANTIA; D. BARNES; F. SELLEBJERG; R.A. RUDICK
Does High-Dose Interferon Beta-1b Improve Clinical Response In More Severely Disabled Multiple Sclerosis Patients ?
2000-01-01 L. DURELLI; A. OGGERO; E. VERDUN; G. ISOARDO; A. RICCI; P. BARBERO; B. BERGAMASCO
Anti-Gm1 And Anti-Sulfatide Antibodies In Polyneuropathies. Threshold Titers And Accuracy
2001-01-01 G.L. ISOARDO; B. FERRERO; P. BARBERO; A. CUCCI; A. OGGERO; A. PIPIERI; A. RICCI; E. VERDUN; B. BERGAMASCO; L. DURELLI
Liver And Thyroid Function And Autoimmunity During Interferon Beta-1b Treatment For Ms.
2001-01-01 L. DURELLI; B. FERRERO; A. OGGERO; E. VERDUN; A.GHEZZI; E. MONTANARI; M. ZAFFARONI; AND THE BETAFERON SAFETY TRIAL BEST STUDY GROUP
Thyroid function and autoimmunity during interferon beta-1b treatment. A multicenter prospective study.
2001-01-01 L. DURELLI; B. FERRERO; A. OGGERO; E. VERDUN; A. GHEZZI; E. MONTANARI; M. ZAFFARONI; BETAFERON SAFETY TRIAL BEST STUDY GROUP.
Effect Of Early Interferon Treatment On Conversion To Definite Multiple Sclerosis: A Randomised Study.
2001-01-01 G. COMI; M. FILIPPI; F.BARKHOF; L. DURELLI; G. EDAN; O. FERNANDEZ; H.P. HARTUNG; P.SEELDRAYERS; P. SOELBERG SORENSEN; M. ROVARIS; F. MARTINELLI; V. MARTINELLI; M. RODEGHER; G. FRANCIS; O.R. HOMMES; ETOMS STUDY GROUP
Lo studio INCOMIN (the indipendent comparison of interferon): trial multicentrico randomizzato di confronto dell’efficacia clinica e di risonanza magnetica nucleare degli interferoni beta-1a e beta 1-b nella Sclerosi Multipla.
2001-01-01 A. PIPIERI; E. VERDUN; P; BARBERO; M. BERGUI; B. FERRERO; A; OGGERO; M. CLERICO; A; GHEZZI; E. MONTANARI; M. ZAFFARONI; L. DURELLI
Terapia cronica con interferone beta. risultati, efetti collaterali e gestione a lungo termine.
2001-01-01 L. DURELLI
La terapia della sclerosi multipla nell’esperienza quotidiana del neurologo. Dalla prognosi alla terapia
2001-01-01 L. DURELLI
Lo studio INCOMIN. Scelta dell’Interferone Beta ottimale
2001-01-01 L. DURELLI; ELISABETTA VERDUN; PIERANGELO BARBERO; ALESSANDRA OGGERO; ANGELO GHEZZI; ENRICO MONTANARI; MAURO ZAFFARONI; E IL GRUPPO DI STUDIO INCOMIN.
Interferon-Beta Dose And Efficacy: The Optims Study
2001-01-01 L. DURELLI; A. OGGERO; E. VERDUN; P. BARBERO; A. PIPIERI; G. ISOARDO; A. RICCI; M. CLERICO; G. BRADAC; B. BERGAMASCO; M. BERGUI.
Terapia cronica con interferone beta : la scelta della dose ottimale
2001-01-01 P. BARBERO; L. DURELLI
Diffusion-weighted MR in reversible Wernicke encephalopathy
2001-01-01 M. Bergui; G. B. Bradac; J. J. Zhong; P. A. Barbero; L. Durelli
Terminal latency index in polyneuropathy with IgM paraproteinemia and anti-MAG antibody.
2001-01-01 D. COCITO; G. ISOARDO; P. CIARAMITARO; G. MIGLIARETTI; A. PIPIERI; P. BARBERO; L. DURELLI
The Independent Comparison of Interferon (INCOMIN) trial: A multicenter randomized trial comparing clinical and MRI efficacy of IFN beta-1a and beta-1b in multiple sclerosis
2001-01-01 L. Durelli; B. Ferrero; A. Ghezzi; E. Montanari; M. Zaffaroni; M. Bergui; E. Verdun; P. Barbero
Thyroid function and anti-thyroid antibodies in MS patients screened for interferon treatment. A multicenter study.
2001-01-01 DURELLI L; OGGERO A; VERDUN E; ISOARDO GL; BARBERO P; BERGAMASCO B; BROSSA PC; GHIGO E; MACCARIO M; FAGGIANO F.
Hypotalamic-pituitary adrenal axis function in relapsing-remitting multiple sclerosis before and during treatment with interferon-beta
2002-01-01 Limone P.; Ferrero B.; Calvelli P.; Del Rizzo P.; Rota E.; Barberis A.M.; Isaia GC.; Durelli L.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Effects of taurine in chronic experimental epilepsy. | 1974 | MUTANI R ;BERGAMINI L ;DELSEDIME M ;DURELLI L | |
Interferon alpha-2a treatment of relapsing-remitting multiple sclerosis: Disease activity resumes after stopping treatment | 1996 | L. Durelli; M. R. Bongioanni; B. Ferrero; R. Ferri; D. Imperiale; G. B. Bradac; M. Bergui; M. Geuna; L. Bergamini; B. Bergamasco | |
Autoimmune events during interferon beta-1b treatment for multiple sclerosis. | 1999 | DURELLI L; FERRERO B; OGGERO A; VERDUN E; BONGIOANNI MR; GENTILE E; ISOARDO GL; RICCI A; ROTA E; BERGAMASCO B; M. DURAZZO; SARACCO G; BIAVA MA; BROSSA PC; GIORDA L; PAGNI R; AIMO G | |
A Meta-Analysis Of Methylprednisolone In Recovery From Multiple Sclerosis Exacerbations | 2000 | D.M. MILLER; B. WEINSTOCK-GUTTMAN; F. BTHOUX; J. LEE; G. BECK; V. BLOCK; L. DURELLI; L. LAMANTIA; D. BARNES; F. SELLEBJERG; R.A. RUDICK | |
Does High-Dose Interferon Beta-1b Improve Clinical Response In More Severely Disabled Multiple Sclerosis Patients ? | 2000 | L. DURELLI; A. OGGERO; E. VERDUN; G. ISOARDO; A. RICCI; P. BARBERO; B. BERGAMASCO | |
Anti-Gm1 And Anti-Sulfatide Antibodies In Polyneuropathies. Threshold Titers And Accuracy | 2001 | G.L. ISOARDO; B. FERRERO; P. BARBERO; A. CUCCI; A. OGGERO; A. PIPIERI; A. RICCI; E. VERDUN; B. BERGAMASCO; L. DURELLI | |
Liver And Thyroid Function And Autoimmunity During Interferon Beta-1b Treatment For Ms. | 2001 | L. DURELLI; B. FERRERO; A. OGGERO; E. VERDUN; A.GHEZZI; E. MONTANARI; M. ZAFFARONI; AND THE BETAFERON SAFETY TRIAL BEST STUDY GROUP | |
Thyroid function and autoimmunity during interferon beta-1b treatment. A multicenter prospective study. | 2001 | L. DURELLI; B. FERRERO; A. OGGERO; E. VERDUN; A. GHEZZI; E. MONTANARI; M. ZAFFARONI; BETAFERON SAFETY TRIAL BEST STUDY GROUP. | |
Effect Of Early Interferon Treatment On Conversion To Definite Multiple Sclerosis: A Randomised Study. | 2001 | G. COMI; M. FILIPPI; F.BARKHOF; L. DURELLI; G. EDAN; O. FERNANDEZ; H.P. HARTUNG; P.SEELDRAYERS; P. SOELBERG SORENSEN; M. ROVARIS; F. MARTINELLI; V. MARTINELLI; M. RODEGHER; G. FRANCIS; O.R. HOMMES; ETOMS STUDY GROUP | |
Lo studio INCOMIN (the indipendent comparison of interferon): trial multicentrico randomizzato di confronto dell’efficacia clinica e di risonanza magnetica nucleare degli interferoni beta-1a e beta 1-b nella Sclerosi Multipla. | 2001 | A. PIPIERI; E. VERDUN; P; BARBERO; M. BERGUI; B. FERRERO; A; OGGERO; M. CLERICO; A; GHEZZI; E. MONTANARI; M. ZAFFARONI; L. DURELLI | |
Terapia cronica con interferone beta. risultati, efetti collaterali e gestione a lungo termine. | 2001 | L. DURELLI | |
La terapia della sclerosi multipla nell’esperienza quotidiana del neurologo. Dalla prognosi alla terapia | 2001 | L. DURELLI | |
Lo studio INCOMIN. Scelta dell’Interferone Beta ottimale | 2001 | L. DURELLI; ELISABETTA VERDUN; PIERANGELO BARBERO; ALESSANDRA OGGERO; ANGELO GHEZZI; ENRICO MONTANARI; MAURO ZAFFARONI; E IL GRUPPO DI STUDIO INCOMIN. | |
Interferon-Beta Dose And Efficacy: The Optims Study | 2001 | L. DURELLI; A. OGGERO; E. VERDUN; P. BARBERO; A. PIPIERI; G. ISOARDO; A. RICCI; M. CLERICO; G. BRADAC; B. BERGAMASCO; M. BERGUI. | |
Terapia cronica con interferone beta : la scelta della dose ottimale | 2001 | P. BARBERO; L. DURELLI | |
Diffusion-weighted MR in reversible Wernicke encephalopathy | 2001 | M. Bergui; G. B. Bradac; J. J. Zhong; P. A. Barbero; L. Durelli | |
Terminal latency index in polyneuropathy with IgM paraproteinemia and anti-MAG antibody. | 2001 | D. COCITO; G. ISOARDO; P. CIARAMITARO; G. MIGLIARETTI; A. PIPIERI; P. BARBERO; L. DURELLI | |
The Independent Comparison of Interferon (INCOMIN) trial: A multicenter randomized trial comparing clinical and MRI efficacy of IFN beta-1a and beta-1b in multiple sclerosis | 2001 | L. Durelli; B. Ferrero; A. Ghezzi; E. Montanari; M. Zaffaroni; M. Bergui; E. Verdun; P. Barbero | |
Thyroid function and anti-thyroid antibodies in MS patients screened for interferon treatment. A multicenter study. | 2001 | DURELLI L; OGGERO A; VERDUN E; ISOARDO GL; BARBERO P; BERGAMASCO B; BROSSA PC; GHIGO E; MACCARIO M; FAGGIANO F. | |
Hypotalamic-pituitary adrenal axis function in relapsing-remitting multiple sclerosis before and during treatment with interferon-beta | 2002 | Limone P.; Ferrero B.; Calvelli P.; Del Rizzo P.; Rota E.; Barberis A.M.; Isaia GC.; Durelli L. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile